Fate Therapeutics Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Fate Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.74. The average 1-year stock price forecast is 136.21% higher than the current stock price, while the lowest is $2.20 (-9.47%) and the highest is $8.00 (+229.22%).

Price Target: $5.74 (+136.21%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$2.20	$5.74	$7.00	$8.00
Change	-9.47%	+136.21%	+188.07%	+229.22%

Analyst Ratings

The average analyst rating for Fate Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	5	4	5	5	5	4
Buy	1	1	1	1	1	1
Hold	6	6	6	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	11	12	12	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Mizuho Securities No rating	Mizuho Securities	Buy Maintains $8	Buy	Maintains	$8	+229.22%	Aug 17, 2026
Unknown Analyst Wedbush No rating	Wedbush	Buy Maintains $7	Buy	Maintains	$7	+188.07%	Aug 14, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $6 → $8	Buy	Reiterates	$6 → $8	+229.22%	Aug 14, 2026
Unknown Analyst Wells Fargo No rating	Wells Fargo	Hold Reiterates $2.5 → $3.5	Hold	Reiterates	$2.5 → $3.5	+44.03%	Aug 14, 2026
Gil Blum Needham	Needham	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Aug 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

5.84M

from 6.65M

-12.15%

from 6.65M

Revenue Next Year

4.77M

from 5.84M

-18.36%

from 5.84M

EPS This Year

-1.02

from -1.15

EPS Next Year

-0.97

from -1.02

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	55.85M	96.30M	63.53M	13.63M	6.65M	5.84M
Revenue Growth	77.66%	72.44%	-34.03%	-78.55%	-51.24%	-12.15%
Operating Income	-216.99M	-308.39M	-190.51M	-195.54M	-146.60M	-134.68M
Net Income	-212.15M	-281.72M	-160.93M	-186.26M	-136.32M	-128.18M
EPS	-	-	-	-	-1.15	-1.02
Free Cash Flow	-134.71M	-148.77M	-82.31M	-60.77M	-51.56M	-111.00M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	8.4M
Avg	5.8M
Low	3.4M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	26.4%
Avg	-12.2%
Low	-49.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.88
Avg	-1.02
Low	-1.11

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-